Acta Chir Orthop Traumatol Cech. 2021; 88(5):339-343 | DOI: 10.55095/achot2021/050

The Association of Interleukin-6 (IL-6) -572G/C and Transforming Growth Factor Beta 1 (TGFB1) 29C/T Single Nucleotide Polymorphisms (SNPs) with Developmental Dysplasia of the Hip: a Case Control StudyOriginal papers

S. İĞREK1,*, T. ONAY2, A. H. AKGÜLLE3, M. POLAT3, A. I. GÜNEY3, H. H. MURATLI3
1 Selahaddin Eyyubi State Hospital, Department of Orthopaedics and Traumatology, Diyarbakir, Turkey
2 Lütfi Kirdar Kartal Training and Research Hospital, Department of Orthopaedics and Traumatology, Istanbul, Turkey
3 Marmara University, Faculty of Medicine, Department of Orthopaedics and Traumatology, Istanbul, Turkey

PURPOSE OF THE STUDY:
The aim of the present study was to determine the potential effects of single nucleotide polymorphisms (SNPs) of TGFB1 and IL-6 on the development and severity of the disease in patients with DDH and investigate the relationship of these two gene polymorphisms.

MATERIAL AND METHODS:
This case control study was conducted on 105 patients diagnosed with DDH and 119 healthy control subjects of any age. The DDH patients were classified according to the Hartofilakidis and IHDI classifications for adult and pediatric patients, respectively. Genomic DNA was isolated from peripheral blood samples using the Salting-out method. TGFB1 gene p.Pro10Leu (c.29C>T) (rs1800470) and IL-6 572G>C (rs1800796) polymorphisms were analyzed using Sanger DNA sequencing.

RESULTS:
There was no statistically significant relationship of TGFB1 and IL-6 SNPs for DDH. When the rs1800470 and rs1800796 polymorphisms were compared according to family history, the homozygous mutation rate of TGFB1 gene was found to be significantly higher in patients with a positive family history than in patients with a negative family history. No significant relationship was found between rs1800796 polymorphisms and family history. TGFB1 homozygous mutation rate was determined to be statistically higher in the positive family history group than control group. No similar relationship was found between the negative family history group and the control group. No statistically significant relationship was determined between rs1800470 and rs1800796 and the severity of DDH.

CONCLUSIONS:
rs1800796 and rs1800470 polymorphisms do not appear to be major responsible genetic factors for DDH. However, the determination of a correlation between a positive family history and homozygous mutation rate of the TGFB1 gene indicates that this gene may have a greater effect on DDH development.

Keywords: developmental dysplasia of the hip, interleukin-6, transforming growth factor beta 1, case control study

Published: October 15, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
İĞREK S, ONAY T, AKGÜLLE AH, POLAT M, GÜNEY AI, MURATLI HH. The Association of Interleukin-6 (IL-6) -572G/C and Transforming Growth Factor Beta 1 (TGFB1) 29C/T Single Nucleotide Polymorphisms (SNPs) with Developmental Dysplasia of the Hip: a Case Control Study. Acta Chir Orthop Traumatol Cech. 2021;88(5):339-343. doi: 10.55095/achot2021/050. PubMed PMID: 34738892.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Basit S, Hannan MA, Khoshhal KI. Developmental dysplasia of the hip: usefulness of next generation genomic tools for characterizing the underlying genes - a mini review. Clin Genet. 2016;90:16-20. Go to original source... Go to PubMed...
    2. Èengiæ T, Trkulja V, Paveliæ SK, Ratkaj I, Markova-Car E, Mikolauèiæ M, Kolund¾iæ R. Association of TGFB1 29C/T and IL6 - 572G/C polymorphisms with developmental hip dysplasia: a case-control study in adults with severe osteoarthritis. Int Orthop. 2015;39:793-798. Go to original source... Go to PubMed...
    3. Ceylaner G, Ceylaner S, Ustünkan F, Inan M. [Autosomal dominant inheritance of congenital dislocation of the hip in 16 members of a family]. Acta Orthop Traumatol Turc. 2008;42:289-291. Go to original source... Go to PubMed...
    4. Clinical practice guideline: early detection of developmental dysplasia of the hip. Committee on Quality Improvement, Subcommittee on Developmental Dysplasia of the Hip. American Academy of Pediatrics. Pediatrics. 2000;105(4Pt 1):896-905. Go to original source... Go to PubMed...
    5. Dezateux C, Rosendahl K. Developmental dysplasia of the hip. Lancet. 2007;369:1541-1552. Go to original source... Go to PubMed...
    6. Finnson KW, Chi Y, Bou-Gharios G, Leask A, Philip A. TGF-b signaling in cartilage homeostasis and osteoarthritis. Front Biosci (Schol Ed). 2012;4:251-268. Go to original source... Go to PubMed...
    7. Gkiatas I, Boptsi A, Tserga D, Gelalis I, Kosmas D, Pakos E. Developmental dysplasia of the hip: a systematic literature review of the genes related with its occurrence. EFORT Open Rev. 2019;4:595-601. Go to original source... Go to PubMed...
    8. Kwan Tat S, Padrines M, Théoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004;15:49-60. Go to original source... Go to PubMed...
    9. Kenanidis E, Gkekas NK, Karasmani A, Anagnostis P, Christofilopoulos P, Tsiridis E. Genetic Predisposition to Developmental Dysplasia of the Hip. J Arthroplasty. 2020;35:291-300. Go to original source... Go to PubMed...
    10. Kokavec M, Bialik V. Developmental dysplasia of the hip. Prevention and real incidence. Bratisl Lek Listy. 2007;108:251-254. Go to PubMed...
    11. Kolund¾iæ R, Trkulja V, Mikolauèiæ M, Kolund¾iæ MJ, Paveliæ SK, Paveliæ K. Association of interleukin-6 and transforming growth factor-β1 gene polymorphisms with developmental hip dysplasia and severe adult hip osteoarthritis: a preliminary study. Cytokine. 2011;54:125-128. Go to original source... Go to PubMed...
    12. Loder RT, Skopelja EN. The epidemiology and demographics of hip dysplasia. ISRN Orthop. 2011;2011:238607. Go to original source... Go to PubMed...
    13. Malemud CJ. Anticytokine therapy for osteoarthritis: evidence to date. Drugs Aging. 2010;27:95-115. Go to original source... Go to PubMed...
    14. Ma W, Zha Z, Chen K, Chen H, Wu Y, Ma J, Zeng S, Zhi L, Yao S. Genetic association study of common variants in TGFB1 and IL-6 with developmental dysplasia of the hip in Han Chinese population. Sci Rep. 2017;7:10287. Go to original source... Go to PubMed...
    15. Narayanan U, Mulpuri K, Sankar WN, Clarke NM, Hosalkar H, Price CT; International Hip Dysplasia Institute. Reliability of a new radiographic classification for developmental dysplasia of the hip. J Pediatr Orthop. 2015;35:478-484. Go to original source... Go to PubMed...
    16. Onay T, Gumustas SA, Cagirmaz T, Aydemir AN, Orak MM. Do the risk factors for developmental dysplasia of the hip differ according to gender? A look from another perspective. J Paediatr Child Health. 2019;55:168-174. Go to original source... Go to PubMed...
    17. Pola E, Papaleo P, Pola R, Gaetani E, Tamburelli FC, Aulisa L, Logroscino CA. Interleukin-6 gene polymorphism and risk of osteoarthritis of the hip: a case-control study. Osteoarthritis Cartilage. 2005;13:1025-1028. Go to original source... Go to PubMed...
    18. Songur M, Akel I, Karahan S, Kuzgun U, Tumer Y. Prevalence of untreated hip dislocation in Turkish children aged 6 months to 14 years. Acta Orthop Traumatol Turc. 2011;45:215-220. Go to original source... Go to PubMed...
    19. Stevenson DA, Mineau G, Kerber RA, Viskochil DH, Schaefer C, Roach JW. Familial predisposition to developmental dysplasia of the hip. J Pediatr Orthop. 2009;29:463-466. Go to original source... Go to PubMed...
    20. Vaughn SP, Broussard S, Hall CR, Scott A, Blanton SH, Milunsky JM, Hecht JT. Confirmation of the mapping of the Camurati-Englemann locus to 19q13. 2 and refinement to a 3.2-cM region. Genomics. 2000;66:119-121. Go to original source... Go to PubMed...
    21. Zamborsky R, Kokavec M, Harsanyi S, Attia D, Danisovic L. Developmental dysplasia of hip: perspectives in genetic screening. Med Sci (Basel). 2019;7:59. Go to original source... Go to PubMed...
    22. Zilberstein A, Ruggieri R, Korn JH, Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 1986;5:2529-2537. Go to original source... Go to PubMed...

    Return to the content